Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammationJournal of neuroinflammation, 2020-02, Vol.17 (1), p.48-48, Article 48 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1742-2094 ;EISSN: 1742-2094 ;DOI: 10.1186/s12974-020-1727-6 ;PMID: 32019570Full text available |
|
2 |
Material Type: Article
|
MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cellsExperimental and Molecular Medicine, 2019, 51(0), , pp.1-11 [Peer Reviewed Journal]2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1226-3613 ;EISSN: 2092-6413 ;DOI: 10.1038/s12276-019-0344-x ;PMID: 31723119Full text available |
|
3 |
Material Type: Article
|
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse modelFluids and barriers of the CNS, 2023-02, Vol.20 (1), p.9-9, Article 9 [Peer Reviewed Journal]2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-8118 ;EISSN: 2045-8118 ;DOI: 10.1186/s12987-023-00410-x ;PMID: 36726154Full text available |
|
4 |
Material Type: Article
|
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injuryJournal of inflammation (London, England), 2023-04, Vol.20 (1), p.13-13, Article 13 [Peer Reviewed Journal]2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1476-9255 ;EISSN: 1476-9255 ;DOI: 10.1186/s12950-023-00338-x ;PMID: 37024954Full text available |
|
5 |
Material Type: Article
|
A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathwayFrontiers in pharmacology, 2023-11, Vol.14, p.1275749-1275749 [Peer Reviewed Journal]Copyright © 2023 Park, Zhang, Kwak, Gadhe, Kim, Kim, Noh, Shin, Ha and Kwon. 2023 Park, Zhang, Kwak, Gadhe, Kim, Kim, Noh, Shin, Ha and Kwon ;ISSN: 1663-9812 ;EISSN: 1663-9812 ;DOI: 10.3389/fphar.2023.1275749Full text available |
|
6 |
Material Type: Article
|
CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injuryExperimental and Molecular Medicine, 2022, 54(0), , pp.1-12 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1226-3613 ;EISSN: 2092-6413 ;DOI: 10.1038/s12276-021-00720-w ;PMID: 34997212Full text available |
|
7 |
Material Type: Article
|
CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in miceJournal of pharmacological sciences, 2024-02, Vol.154 (2), p.77-85 [Peer Reviewed Journal]Copyright © 2024 The Authors. Production and hosting by Elsevier B.V. All rights reserved. ;ISSN: 1347-8613 ;EISSN: 1347-8648 ;DOI: 10.1016/j.jphs.2023.12.009 ;PMID: 38246731Full text available |
|
8 |
Material Type: Patent
|
CANCER IMMUNOTHERAPHY ADJUVANTDigital Resources/Online E-Resources |
|
9 |
Material Type: Patent
|
Adjuvant for cancer immunotherapyDigital Resources/Online E-Resources |
|
10 |
Material Type: Patent
|
Cancer Immunotherapy AdjuvantDigital Resources/Online E-Resources |
|
11 |
Material Type: Patent
|
CANCER IMMUNOTHERAPHY ADJUVANTDigital Resources/Online E-Resources |
|
12 |
Material Type: Patent
|
CANCER IMMUNOTHERAPHY ADJUVANTDigital Resources/Online E-Resources |